Amit Alfasi, Author at Peregrine

Catiheal - Nir Altschuler

CartiHeal, Makes Biggest Israeli Biomed Exit of 2023

BioProtect Balloon ImplantTM System has been cleared by the FDA

The-Hear-o-app

AstraZeneca launches pilot program for Cordio Medical

KAHR Medical reports dose escalation data from its Phase I trial of DSP107

“It’s a simple daily habit that could save their life” – Cordio Medical coverage in Forbes magazine

Ribon Therapeutics announced dosing of the first patient

Restore announces successful First-In-Human preliminary results of Its CONTRABAND™ system

BioProtect presented successful outcomes from its phase I/II study

Levation Pharma, Ltd. received an FDA clearance to initiate Phase I/II of LEV102

EndoStream Medical announced they are conducting their first case in the US as part of the company’s Clinical Trial